Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
8.1%
% of IXJ's 114 holdings also in XPH
24.3%
% of XPH's 40 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.5% | 5.6% | 5.6% |
|
JOHNSON & JOHNSON | 5.6% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 3.9% | 4.2% | 3.9% |
|
PFIZER INC | 2.8% | 3.8% | 2.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% | 3.9% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to XPH
|
UNITEDHEALTH GROUP INC | 6.5% |
|
ABBVIE INC | 3.8% |
 |
NOVARTIS AG | 3.5% |
 |
ASTRAZENECA PLC | 3.0% |
|
ROCHE HOLDING LTD | 2.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
|
ABBOTT LABORATORIES | 2.5% |
|
DANAHER CORP | 2.4% |
|
AMGEN INC | 2.0% |
 |
SANOFI-AVENTIS | 1.8% |
IXJ Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% |
|
ELANCO ANIMAL HEALTH, INC. | -5.7% |
|
CATALENT INC | -5.3% |
 |
JAZZ PHARMACEUTICALS PLC | -4.5% |
|
AXSOME THERAPEUTICS, INC. | -4.4% |
|
VIATRIS, INC. | -4.3% |
|
ORGANON & CO. | -3.8% |
|
PERRIGO CO | -3.7% |
|
ROYALTY PHARMA PLC CLASS A | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |